Theravance Biopharma - PharmaKB

Company Reports

Company Reports

Disease Reports

Disease Reports

Company ReportsTheravance Biopharma

Theravance Biopharma(TBPH)

Download report

Favorite

Financial

Marketed Drugs

Clinical Trials

Financial

Stock price

*Currency in USD

Company Revenue

Quarterly

Quarterly

Annual

Annual

Projections

*Quarterly sales USD (in millions)

Plot placeholder

Mock data
Subscribe for the real data

Revenue by Drug

Marketed Drugs

Therapeutic Areas:

All

Classification:

All

Include Generics:

Trade Name	Drug Name	Approved	Patent Expires	Indication
Vibativ	Telavancin	2011-09-02	2027	Pneumonia , Cross infection , Bacterial infections , Infectious skin diseases , Streptococcal infections , Bacterial pneumonia , Staphylococcal infections

Clinical Trials

Therapeutic Areas:

All

Classification:

All

Approval:

All

Status:

All

Phases:

All

Drug Name

Phase 1

Phase 2

Phase 3

Phase 4

Indication

healthy volunteers/patients

,

,

,

communicable diseases

,

,

chronic renal insufficiency

,

chronic kidney failure

,

kidney diseases

healthy volunteers/patients

,

coronary artery disease

drug interactions

,

,

myofascial pain syndromes

,

,

shy-drager syndrome

,

,

,

attention deficit disorder with hyperactivity

,

orthostatic hypotension

,

,

pure autonomic failure

,

parkinson disease

,

multiple system atrophy

,

lipid metabolism disorders

,

hypertriglyceridemia

,

cardiovascular diseases

,

follicular lymphoma

,

huntington disease

,

colonic neoplasms

,

healthy volunteers/patients

,

colorectal neoplasms

,

chronic renal insufficiency

,

kidney diseases

,

sickle cell anemia

,

knee osteoarthritis

,

,

,

,

ovarian neoplasms

,

,

ovarian epithelial carcinoma

,

head and neck neoplasms

,

squamous cell carcinoma

,

squamous cell neoplasms

,

laryngeal neoplasms

,

opioid-related disorders

,

,

coronavirus infections

,

,

,

brain neoplasms

,

,

neurofibromatosis 2

,

acoustic neuroma

,

,

,

neurofibromatosis 1

,

neurofibromatoses

,

,

,

,

cystic fibrosis

,

,

biliary tract neoplasms

,

,

urinary bladder neoplasms

,

invasive hydatidiform mole

,

non-muscle invasive bladder neoplasms

,

non-hodgkin lymphoma

,

b-cell chronic lymphocytic leukemia

,

mantle-cell lymphoma

,

b-cell lymphoma

,

b-cell leukemia

,

diabetes mellitus

,

chronic obstructive pulmonary disease

,

,

non-small-cell lung carcinoma

,

,

pulmonary eosinophilia

,

,

,

,

,

endometrial neoplasms

,

borderline personality disorder

,

personality disorders

,

churg-strauss syndrome

,

eosinophilic granuloma

,

type 2 diabetes mellitus

,

breast neoplasms

,

,

,

,

endomyocardial fibrosis

,

postoperative pain

,

,

major depressive disorder

,

depressive disorder

,

systemic lupus erythematosus

,

opioid-induced constipation

,

healthy volunteers/patients

,

prostatic neoplasms

,

breast neoplasms

,

pancreatic neoplasms

,

,

chronic obstructive pulmonary disease

,

,

obstructive lung diseases

ventilator-associated pneumonia

,

iatrogenic disease

,

,

acinetobacter infections

staphylococcal skin infections

,

staphylococcal infections

bacterial infections

healthy volunteers/patients

,

critical illness

,

enteral nutrition

inflammatory bowel diseases

,

intestinal diseases

,

healthy volunteers/patients

,

,

ulcerative colitis

,

,

healthy volunteers/patients

,

ulcerative colitis

gastrointestinal motility

,

critical illness

non-alcoholic fatty liver disease

,

hyperlipidemias

1

2

>

© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use